Stocks › Medical Devices › IART

Integra Lifesciences IART

US equityMarket cap rank #3233Medical Devices Brain-Computer Interface

$13.00 −$0.32 (-2.40%)

Pre-market · Oct 8, 8:20 am ET · After hours $13.00 0.00%

Open$13.19

Prev close$13.32

Day range$12.98 – $13.46

Volume1.41M

Market cap$1.01B

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership106.7%+0.22 pts vs. prior quarter

Institutions holding258+0 vs. prior quarter

Insider trades (recent)30 buys / 19 sellsNet buying

Short interest8.75% of floatDays to cover 8.3 · as of 15 Sep 2026

Short-sale volume share23.1%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.07M (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.9% of shares outstanding.

Largest holders

BlackRock13.74%
Tru St Partnership LP10.95%
Rubric Capital Management LP9.97%
Vanguard Portfolio Management, LLC4.81%
Invesco Ltd.4.43%
Paradigm Capital Management, Inc.4.42%
Fuller & Thaler Asset Management, Inc.4.42%
Vanguard Capital Management, LLC4.36%

By investor type

Mutual Fund74.24%
Hedge Fund15.96%
Private Company11.52%
Individual/Insider3.63%
Public Company3.26%
Government Pension Fund1.33%
Insurance Company0.32%
Government0.03%

Reported short interest has risen from 8.22% to 8.75% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Nuveen Asset Management LLC	Insurance Company	2026/Q3	+160,130	0.2%
Millennium Management LLC	Hedge Fund	2026/Q3	+816,894	1.9%
Integral Health Asset Management, LLC	Hedge Fund	2026/Q3	+550,000	0.7%
BlackRock	Mutual Fund	2026/Q3	+364,934	13.7%
Invesco Ltd.	Mutual Fund	2026/Q3	+354,779	4.4%
PFM Health Sciences, LP	Hedge Fund	2026/Q3	+348,746	0.4%
Neuberger Berman Investment Advisers LLC	Mutual Fund	2026/Q3	+249,522	3.0%
Franklin Resources	Mutual Fund	2026/Q3	+230,554	0.3%
Nuveen Investments	Mutual Fund	2026/Q3	+205,134	0.3%
Marshall Wace LLP	Hedge Fund	2026/Q3	+176,254	0.4%
Wellington Management Group	Mutual Fund	2026/Q3	+160,814	1.9%
Quantinno Capital Management LP	Mutual Fund	2026/Q3	+149,703	0.8%
Geode Capital Management, LLC	Mutual Fund	2026/Q3	+134,650	2.3%
Arrowstreet Capital, Limited Partnership	Mutual Fund	2026/Q3	+131,515	0.2%
IEQ Capital, LLC	Mutual Fund	2026/Q3	+125,262	0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
16 Sep 2026	Lesha Shinn		Initial Statement of Beneficial	+0	–	26,838
31 Aug 2026	Chantal Veillon-Berteloot	Executive Vice President	Sale to Issuer	-1,455	$16.62	20,772
2 Jul 2026	Lea Knight	Chief Financial Officer	Sale to Issuer	-5,226	$18.05	45,263
30 Jun 2026	Robert Davis	Executive VP & President of Tissue Technologies	Other Derivative Acquisition	+11,180	–	54,530
30 Jun 2026	Jeffrey Mosebrook	Senior VP & PAO	Sale to Issuer	-937	$17.89	34,516
30 Jun 2026	Harvinder Singh	Executive VP & President of International Business	Other Derivative Acquisition	+5,590	–	68,883
31 May 2026	Stuart Essig	Independent Chairperson	Other Derivative Acquisition	+365,297	–	365,297
31 May 2026	Stuart Essig	Independent Chairperson	Other Derivative Acquisition	+705,468	$15.67	705,468
31 May 2026	Michael McBreen	Executive VP & President of Codman Specialty Surgical	Other Derivative Acquisition	+31,909	–	124,017
31 May 2026	Michael McBreen	Executive VP & President of Codman Specialty Surgical	Other Derivative Acquisition	+60,372	$15.67	60,372
8 May 2026	Keith N. Bradley	Independent Director	Sale to Issuer	-882	$13.92	88,254
6 May 2026	Christian Schade	Independent Director	Other Derivative Acquisition	+17,700	–	17,700
6 May 2026	Barbara Hill	Independent Director	Other Acquisition	+24,338	–	187,541
6 May 2026	Keith N. Bradley	Independent Director	Other Derivative Acquisition	+17,700	–	17,700
6 May 2026	Jeffrey Graves	Director	Other Derivative Acquisition	+17,700	–	17,700
6 May 2026	Shaundra Clay	Independent Director	Other Derivative Acquisition	+17,700	–	17,700
6 May 2026	Renee Lo	Independent Director	Other Derivative Acquisition	+17,700	–	17,700
10 Mar 2026	Robert Davis	Executive VP & President of Tissue Technologies	Other Derivative Acquisition	+43,350	–	43,350
10 Mar 2026	Mojdeh Poul	Chief Executive Officer	Other Derivative Acquisition	+343,393	–	445,691
10 Mar 2026	Jeffrey Mosebrook	Senior VP & PAO	Other Derivative Acquisition	+15,957	–	15,957

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	6,806,086	8.8%	8.3
31 Aug 2026	6,858,036	8.8%	12.3
14 Aug 2026	6,742,359	8.7%	10.0
31 Jul 2026	6,477,081	8.3%	5.9
15 Jul 2026	6,205,140	8.0%	7.2
30 Jun 2026	6,394,225	8.2%	5.7

Discussion

No comments yet — be the first to weigh in on IART.